Citation

Huang A, Jayaraman L, Fura A, Vite GD, Trainor GL, Gottardis MM, Spires TE, Spires VM, Rizzo CA, Obermeier MT, Elzinga PA, Todderud G, Fan Y, Newitt JA, Beyer SM, Zhu Y, Warrack BM, Goodenough AK, Tebben AJ, Doweyko AM, Gold DL, Balog A.: Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer. ACS Med Chem Lett, Volume 7 (1), 2016

Authors

Balog A., Beyer SM, Doweyko AM, Elzinga PA, Fan Y, Fura A, Gold DL, Goodenough AK, Gottardis MM, Huang A, Jayaraman L, Newitt JA, Obermeier MT, Rizzo CA, Spires TE, Spires VM, Tebben AJ, Todderud G, Trainor GL, Vite GD, Warrack BM, Zhu Y

Journal

ACS Med Chem Lett

Year

2016

DOI

10.1021/acsmedchemlett.5b00310

PubMed

26819663

Machine-readable

REST APIRDF